Phreesia, Inc.

For the period ended Jul 31, 2026. Filed Sep 3, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jul 31, 2026 · Filed Sep 3, 2026

PHR$13.13+1.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 1. Financial Statements:

PART I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

Consolidated Balance Sheets

	July 31, 2026	January 31, 2026
(Unaudited)
Assets
Current:
Cash, cash equivalents and restricted cash (including restricted cash of $— and $1,691 as of July 31, 2026 and January 31, 2026, respectively)	$72,945	$73,830
Settlement assets	26,746	32,999
Accounts receivable, net of allowance for doubtful accounts of $879 and $1,523 as of July 31, 2026 and January 31, 2026, respectively	89,406	97,453
Cardholder receivables	29,351	38,330
Deferred purchase price receivables	14,799	18,003
Accrued interest and fees receivables	723	840
Deferred contract acquisition costs	394	410
Prepaid expenses and other current assets	19,139	17,978
Total current assets	253,503	279,843
Property and equipment, net of accumulated depreciation and amortization of $90,281 and $94,193 as of July 31, 2026 and January 31, 2026, respectively	18,122	20,332
Capitalized internal-use software, net of accumulated amortization of $77,389 and $69,390 as of July 31, 2026 and January 31, 2026, respectively	54,127	54,270
Operating lease right-of-use assets	1,205	2,002
Deferred contract acquisition costs	130	338
Intangible assets, net of accumulated amortization of $18,728 and $13,489 as of July 31, 2026 and January 31, 2026, respectively	74,522	79,761
Goodwill	171,468	170,064
Deferred tax assets	990	1,593
Other assets (includes $1,691 and $— of long-term restricted cash as of July 31, 2026 and January 31, 2026, respectively)	6,669	2,442
Long-term cardholder receivables	59,587	47,723
Long-term deferred purchase price receivables	6,654	5,422
Total Assets	$646,977	$663,790
Liabilities and Stockholders’ Equity
Current:
Settlement obligations	$26,746	$32,999
Current portion of debt and finance lease liabilities	5,281	7,971
Current portion of operating lease liabilities	824	1,254
Accounts payable	12,237	11,477
Accrued expenses	35,706	41,257
Due to healthcare providers	29,737	38,056
Deferred revenue	32,573	49,522
Other current liabilities	731	705
Total current liabilities	143,835	183,241
Long-term debt and finance lease liabilities	61,165	92,117
Operating lease liabilities, non-current	677	1,107
Long-term due to healthcare providers	59,734	45,329
Long-term deferred revenue	4,687	244
Long-term deferred tax liabilities	4,589	4,498
Other long-term liabilities	439	47
Total Liabilities	275,126	326,583
Commitments and contingencies (Note 11)
Stockholders’ Equity:
Preferred stock, undesignated, $0.01 par value—20,000,000 shares authorized as of both July 31, 2026 and January 31, 2026; no shares issued or outstanding as of both July 31, 2026 and January 31, 2026	—	—
Common stock, $0.01 par value—500,000,000 shares authorized as of both July 31, 2026 and January 31, 2026; 63,516,793 and 62,020,186 shares issued as of July 31, 2026 and January 31, 2026, respectively	635	620
Additional paid-in capital	1,212,775	1,181,679
Accumulated deficit	(794,309)	(799,190)
Accumulated other comprehensive loss	(621)	(382)
Treasury stock, at cost, 1,476,215 and 1,355,169 shares as of July 31, 2026 and January 31, 2026, respectively	(46,629)	(45,520)
Total Stockholders’ Equity	371,851	337,207
Total Liabilities and Stockholders’ Equity	$646,977	$663,790

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.